A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Choosing the patient for ambulatory stem cell transplantation
2005
Biology of Blood and Marrow Transplantation
Despite excellent survival of marrow transplantation (BMT) in acquired severe aplastic anemia (SAA) using sibling donors, graftversus-host disease (GVHD) continues to remain a major problem resulting in long-term complications and impaired quality of life. Between Aug 1989 and Aug 2004, 35 patients at our centre with acquired SAA underwent BMT from HLA-identical sibling donors using cyclophosphamide (CY) 50 mg/kg ϫ 4 (days Ϫ5 to Ϫ2) and anti-CD52 MoAb 0.75-1 mg/kg BW as conditioning. Prior to
doi:10.1016/j.bbmt.2004.12.102
fatcat:dwrirmzgmrbohp47uw5qs7ew7u